Bermuda-based PartnerRe Ltd. confirmed that its shareholders voted to approve the proposed acquisition of the Company by EXOR, and all related transactions, at a Special General Meeting of shareholders held at the Company’s offices in Bermuda on Thursday.
“The acquisition of PartnerRe Ltd. by EXOR was originally announced on August 2, 2015,” the company said.
“The Company also announced that its Board of Directors declared a special dividend of $3.00 per share payable to the relevant holders of its common shareholders. The payment of this special dividend is conditional and contingent upon the consummation of EXOR’s acquisition of the Company.
“As previously announced, EXOR’s acquisition of the Company is expected to close during the first quarter of 2016, subject to the satisfaction of certain customary closing conditions, including antitrust and insurance regulatory approvals.
“All required antitrust approvals have been obtained. The insurance regulatory approvals remain on track for the transaction to close during the first quarter of 2016.”
Full content: Business Wire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas